Fixed-Duration Pirtobrutinib Plus Venetoclax with or Without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial
Lindsey E. Roeker,Jennifer A. Woyach,Chan Y. Cheah,Catherine C. Coombs,Nirav N. Shah,William G. Wierda,Manish R. Patel,Nicole Lamanna,Donald E. Tsai,Binoj Nair,Chunxiao Wang, Xiang Zhao,Dan Liu,David Radtke, Sonya Chapman,Narasimha Marella,Samuel C. McNeely,Jennifer R. Brown Blood（2024）
AI 理解论文
溯源树
样例
